Question

In: Nursing

Identify pharmacologic agents for diuresis to reduce preload. Identify positive inotropes.   Identify phosphodiesterase inhibitors. Describe the...

Identify pharmacologic agents for diuresis to reduce preload. Identify positive inotropes.   Identify phosphodiesterase inhibitors. Describe the mechanism of action of ACE inhibitors. Describe the mechanism of action of Human B-type natriuretic peptide. Describe the mechanism of action of Angiotensin II-receptor blockers.   Which of these agents is the most commonly used for left sided heart failure? Right sided heart failure?

Solutions

Expert Solution

Please refer the notes below for detailed answer to the above question :

Thank you.


Related Solutions

Congestive Heart Failure Identify pharmacologic agents for diuresis to reduce preload. Identify positive inotropes.   Identify phosphodiesterase...
Congestive Heart Failure Identify pharmacologic agents for diuresis to reduce preload. Identify positive inotropes.   Identify phosphodiesterase inhibitors. Describe the mechanism of action of ACE inhibitors. Describe the mechanism of action of Human B-type natriuretic peptide. Describe the mechanism of action of Angiotensin II-receptor blockers.   Which of these agents is the most commonly used for left sided heart failure? Right sided heart failure?   You may use narrative writing or a table to answer these questions.
IBMX is isobutyl methyl xanthine, one of several modified xanthines (purines) that act as phosphodiesterase inhibitors....
IBMX is isobutyl methyl xanthine, one of several modified xanthines (purines) that act as phosphodiesterase inhibitors. How and where would IBMX effect the PKA pathway?
Identify interventions that incorporate pharmacologic and non pharmacologic treatments for an individual with GI disorders.
Identify interventions that incorporate pharmacologic and non pharmacologic treatments for an individual with GI disorders.
Identify interventions that incorporate pharmacologic and non pharmacologic treatments for an individual with GI disorders.
Identify interventions that incorporate pharmacologic and non pharmacologic treatments for an individual with GI disorders.
Name agents that enhance the action of PPI (proton pump inhibitors)
Name agents that enhance the action of PPI (proton pump inhibitors)
1. What is the difference between left- and right-sided heart failure? 2. Why are phosphodiesterase inhibitors...
1. What is the difference between left- and right-sided heart failure? 2. Why are phosphodiesterase inhibitors high-alert medications? 3. Why are not all beta blockers indicated in the treatment of heart failure? 4. Are there are any laboratory values specifically related to ACE inhibitor administration that need to be monitored for safe drug administration? 5. Order: cefuroxime axetil (Ceftin) 200 mg, PO, b.i.d. Available: Ceftin 250 mg/5 mL How many mL will the patient receive per dose?
1.What is the difference between left- and right-sided heart failure? 2. Why are phosphodiesterase inhibitors high-alert...
1.What is the difference between left- and right-sided heart failure? 2. Why are phosphodiesterase inhibitors high-alert medications? 3. Why are not all beta blockers indicated in the treatment of heart failure? 4. Are there are any laboratory values specifically related to ACE inhibitor administration that need to be monitored for safe drug administration? 5. Order: cefuroxime axetil (Ceftin) 200 mg, PO, b.i.d. Available: Ceftin 250 mg/5 mL How many mL will the patient receive per dose
Identify and describe what threat agents should be avoided in preparation for an assessment. How do...
Identify and describe what threat agents should be avoided in preparation for an assessment. How do we effectively screen out irrelevant threats and attacks in this preparation?
Describe the nurse’s role in the pharmacologic management of coagulation disorders (please explain)
Describe the nurse’s role in the pharmacologic management of coagulation disorders (please explain)
Identify the main patient-related conditions and other applicable factors that contraindicate safe use of phosphodiesterase type...
Identify the main patient-related conditions and other applicable factors that contraindicate safe use of phosphodiesterase type 5 (PDE5) inhibitors. Also, in doing so, describe the main systemic hemodynamic effects of the drug.
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT